Patient-Focused R&D

By staying true to our core scientific expertise and focusing on diseases with significant unmet needs where we believe our scientific capabilities give us a unique advantage, we are working to ensure our long-term success and continued ability to make a real difference in patients’ lives.

Innovation distinguishes Biogen Idec. Within our areas of expertise — neurology, hematology and immunology — we continue to identify adjacencies where the science leads us. Some examples include:

  • Neurology: We are performing research to better understand the biology of complex neurological conditions such as MS, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS).
  • Hematology: We broadened our focus on hemophilia and other hematologic conditions. Through our recent agreement with Sangamo BioSciences, we are working to advance research in sickle-cell anemia and betathalassemia.
  • Immunology: With a current focus on diseases such as lupus and scleroderma in our pipeline, we also plan to move further into related areas of fibrotic diseases and potentially tissue injury and repair. We have established an internal research group to pursue these conditions.

For more information on our R&D initiatives, please see our 2013 Corporate Citizenship Report and the Research & Development section of our website.